NewAmsterdam Pharma Company N.V. NAMSW
As ofNov 20, 2026, 12:50 PM EST
- YTD
- -67.83%
- 1 year
- -73.98%
Ownership
- Institutions 0.00%
- Insiders 0.00%
- Public and other holders 100.0%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 10.88% | 500,333 | 4.70M | Sep 29, 2026 |
| RA Capital Management, L.P. | 7.25% | 333,333 | 3.13M | Sep 29, 2026 |
| Affinity Asset Advisors, Llc | 5.33% | 245,000 | 2.30M | Sep 29, 2026 |
| Bain Capital Life Sciences Investors, LLC | 2.17% | 99,999 | 939.99K | Sep 29, 2026 |
| Deerfield Management Company, L.P | 2.02% | 92,787 | 872.20K | Sep 29, 2026 |
| Wolverine Asset Management, LLC | 0.38% | 17,464 | 164.16K | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| JNL Series Trust-JNL/Westchester Capital Event Driven Fund | 0.14% | 6,630 | 62.32K | Dec 30, 2023 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs NAMSW, and what each was last paid
Michael Harvey Davidson FACC Facp., CEO, President & Executive DirectorAverage age 57
| Name | Title | Pay | Age |
|---|---|---|---|
| Michael Harvey Davidson FACC Facp. | CEO, President & Executive Director | $1.14M | 70 |
| Johannes Jacob Pieter Kastelein FESC | Founder, Chief Scientific Officer, Member of Executive Board & Director | $808K | 72 |
| Mayur Amrat Somaiya | Chief Financial Officer | $770K | 52 |
| Juliette Audet | Chief Strategy & Business Officer | $653K | 39 |
| Michael F. Marino | Chief Legal Officer & Corporate Secretary | — | 50 |
| Robert W. Gunning CGMA | Principal Accounting Officer, VP & Controller | — | 55 |
| Maryellen McQuade | Chief People Officer | — | — |
| Marc Ditmarsch | Chief Development Officer | — | 59 |
| Chris Deluzio | Executive Vice President of Sales Enterprise Operations | — | — |
| Matthew Philippe | Executive VP & Head of Investor Relations | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
No insider holdings on record
